Bizily Scott's Form 4 filing
4D Molecular Therapeutics, Inc. (FDMT) · filed Feb 12, 2024
- Accession no.
- 0000950170-24-014119
- Filed
- Feb 12, 2024
- Trade date
- Feb 8, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $171.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bizily ScottCIK 0001920738 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock | MOption exerciseAcquired | +1,332 | $6.49 | +$8,644.68 | 3,069 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −1,332 | $27.50 | −$36,630 | 1,737 | Direct | |
| Feb 8, 2024 | Common Stock | MOption exerciseAcquired | +2,916 | $8.04 | +$23,444.64 | 4,653 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −2,916 | $27.50 | −$80,190 | 1,737 | Direct | |
| Feb 8, 2024 | Common Stock | MOption exerciseAcquired | +1,996 | $15.78 | +$31,496.88 | 3,733 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −1,996 | $27.50 | −$54,890 | 1,737 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock | MOption exerciseDisposed | −1,332 | $0.00 | $0 | 17,043 | Direct | |
| Feb 8, 2024 | Common Stock | MOption exerciseDisposed | −2,916 | $0.00 | $0 | 45,834 | Direct | |
| Feb 8, 2024 | Common Stock | MOption exerciseDisposed | −1,996 | $0.00 | $0 | 23,004 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.